Atrial septal defect percutaneous closure complications: Difference between revisions
No edit summary |
|||
| Line 3: | Line 3: | ||
==Overview== | ==Overview== | ||
As with any invasive treatment, percutaneous closure | As with any invasive treatment, [[Atrial septal defect percutaneous closure | percutaneous closure]] could be associated with potential complications. Common complications include issues with device functional integrity such as [[emboli]]zation around the device or erosion of the materials and malpositioning. Other complications include potential for development of serious circulatory conditions such as [[atrial fibrillation]], [[heart block]], and [[thrombus]] formation.The disadvantages are a thick profile of the device and concerns related to a large amount of '''nitinol''' (a nickel-titanium compound) in the device and consequent potential for [[nickel toxicity]]. | ||
==Complications== | ==Complications== | ||
Revision as of 15:52, 3 September 2011
|
Atrial Septal Defect Microchapters | |
|
Treatment | |
|---|---|
|
Surgery | |
|
| |
|
Special Scenarios | |
|
Case Studies | |
|
Atrial septal defect percutaneous closure complications On the Web | |
|
American Roentgen Ray Society Images of Atrial septal defect percutaneous closure complications | |
|
FDA on Atrial septal defect percutaneous closure complications | |
|
CDC on Atrial septal defect percutaneous closure complications | |
|
Atrial septal defect percutaneous closure complications in the news | |
|
Blogs on Atrial septal defect percutaneous closure complications | |
|
Risk calculators and risk factors for Atrial septal defect percutaneous closure complications | |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editors-In-Chief: Priyamvada Singh, MBBS [[2]]; Cafer Zorkun, M.D., Ph.D. [3]; Assistant Editor-In-Chief: Kristin Feeney, B.S. [[4]]
Overview
As with any invasive treatment, percutaneous closure could be associated with potential complications. Common complications include issues with device functional integrity such as embolization around the device or erosion of the materials and malpositioning. Other complications include potential for development of serious circulatory conditions such as atrial fibrillation, heart block, and thrombus formation.The disadvantages are a thick profile of the device and concerns related to a large amount of nitinol (a nickel-titanium compound) in the device and consequent potential for nickel toxicity.
Complications
Complications associated with percutaneous closure include:
- Device embolization
- Malposition of device
- Device erosion
- Atrial fibrillation or supraventricular tachycardia
- Transient antrioventricular block/heart block
- Pericardial effusion
- Thrombus formation (on the left atrial appendage)
- Iliac vein dissection
- Groin hematoma
- Cardiac perforation
- Increased levels of cardiac tropnin I
- Residual shunts
Frequency of complications is low, manifesting in under 9% of all cases. With experienced, skilled clinicians, the rate of complication may be as low as 1%.[1]
References
- ↑ Chessa M, Carminati M, Butera G, Bini RM, Drago M, Rosti L; et al. (2002). "Early and late complications associated with transcatheter occlusion of secundum atrial septal defect". J Am Coll Cardiol. 39 (6): 1061–5. PMID 11897451.